ArticleMedicina oral, patologia oral y cirugia bucal2026
Use of topical Vitamin E in oral mucositis in patients undergoing oncology treatment. Scoping review.
Article in Medicina oral, patologia oral y cirugia bucal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral mucositis (OM) refers to lesions characterized by erythema and ulceration of the oral mucosa, commonly observed in cancer patients undergoing chemotherapy (CT) and/or radiotherapy (RT). Currently, there is no specific therapy supported by robust scientific evidence for the treatment of OM-related lesions. However, the literature suggests that antioxidants such as vitamin E may help prevent oxidative cellular damage and limit tissue injury caused by free radicals, potentially reducing the severity of OM during cancer treatment. This review aims to analyze the existing literature on the use of topical vitamin E and its effects on oral mucositis lesions induced by cancer therapy. MATERIAL AND
methodsThis scoping review was conducted in accordance with the PRISMA-ScR guidelines. A comprehensive search was performed in Web of Science (WOS), PubMed, and Scopus databases using the keywords: "vitamin E", "oral mucositis", "chemotherapy", and "radiotherapy". Studies published between 1990 and 2025 were considered for inclusion.
resultsA total of 167 articles were identified. After screening and eligibility assessment, 7 clinical trials were included in the review 4 involving pediatric populations and 3 involving adults. Six of the studies reported favorable outcomes in the vitamin E group compared to placebo, including improved healing, reduced symptom severity, and shorter duration of oral mucositis.
conclusionBased on the studies included in this review, topical vitamin E appears to offer beneficial effects in mitigating the severity and duration of oral mucositis lesions in patients undergoing cancer treatment. However, no standardized protocol currently exists regarding dosage, mode of application (therapeutic vs. preventive), or duration of treatment. Further clinical trials are warranted to establish clear guidelines for the use of topical vitamin E in this context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.